GNOMvsPEPTETF Comparison
VS
Global X Genomics & Biotechnology ETF (GNOM) and REX Peptide ETF (PEPT) belong to the same industry segment: BioTech & Genomics. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.65% for PEPT. Run a side-by-side ETF comparison of GNOM and PEPT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNOM vs PEPT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM PEPT | -1.05%n/a | +25.40%n/a | +52.77%n/a | +58.77%n/a | +98.83%n/a | -19.70%n/a |
| Flows | GNOM PEPT | +$11M- | +$10M- | +$29M- | +$24M- | -$92M- | -$42M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM PEPT | +44.18%n/a | +32.73%n/a | +31.10%n/a | +34.24%n/a |
| Max drawdown | GNOM PEPT | -10.60%n/a | -18.16%n/a | -43.10%n/a | -68.81%n/a |
| Max drawdown duration | GNOM PEPT | 23dn/a | 145dn/a | 674dn/a | 1821dn/a |
Trading data
GNOM | PEPT | |
Last sale 10/30/2026 at 1:30 PM | $69.61 | $27.01 |
| Previous close 10/29/2026 | $72.54 | $26.89 |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNOM | PEPT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
GNOM | PEPT | |
|---|---|---|
| Last price | $69.61 | $27.01 |
| 1D performance | -4.04% | +0.45% |
| AuM | $112.92 M | $1.89 M |
| E/R | 0.5% | 0.65% |
Characteristics
GNOM | PEPT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Global X | REX Shares |
| Benchmark | Solactive Genomics Index | VettaFi Peptide Index |
| N° of holdings | - | - |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | October 14, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNOM
Data will be available soon
PEPT
Data will be available soon
Sectors
GNOM
Data will be available soon
PEPT
Data will be available soon
Advertisement
Diversification
GNOM
Data will be available soon
PEPT
Data will be available soon
Top 15 holdings
Data as of January 1, 1970
GNOM
Data will be available soon
PEPT
Data will be available soon
Frequently asked questions about GNOM and PEPT
Which ETF is bigger: GNOM or PEPT?
As of October 30, 2026, GNOM holds $112.92 M in assets under management (AUM), while PEPT manages $1.89 M.
Advertisement
Advertisement
